title: Nystatin versus amphotericin B to prevent and eradicate Candida colonization during selective digestive tract decontamination in critically ill patients.
authors.affiliation: Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
authors.forename: Bastiaan H
authors.initials: BH
authors.lastname: Wittekamp
authors.affiliation: Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands. davidsyong@gmail.com.|Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. davidsyong@gmail.com.|Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands. davidsyong@gmail.com.|, G04.614 Postbus 85500, 3508 GA, Utrecht, The Netherlands. davidsyong@gmail.com.
authors.forename: David S Y
authors.initials: DS
authors.lastname: Ong
authors.affiliation: Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
authors.forename: Olaf L
authors.initials: OL
authors.lastname: Cremer
authors.affiliation: Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.|Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.
authors.forename: Marc J M
authors.initials: MJ
authors.lastname: Bonten
mesh_terms: D000666:Amphotericin B / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D002175:Candida / Q000187:drug effects*; D016638:Critical Illness; D003666:Decontamination; D041981:Gastrointestinal Tract / Q000382:microbiology*; D006801:Humans; D009761:Nystatin / Q000627:therapeutic use*
chemical_list: D000935:Antifungal Agents; D009761:Nystatin; D000666:Amphotericin B